Hippocratic AI

Most health systems, payors and pharma teams know which patients they should be calling. The post-discharge pneumonia patient who might stop taking antibiotics. The member overdue for a colorectal screening. The joint replacement patient who's quietly skipping physical therapy. The problem isn't knowing. It's that there aren't enough nurses and care managers to make every call, so outreach gets rationed and gaps in care stay open. Hippocratic AI frames this directly: it says healthcare has always been designed "assuming clinical scarcity," and its pitch is that generative AI can make that outreach abundant instead of rationed.

The product is a library of clinical voice agents, which the company says number "1000+," built for specific jobs: Annual Wellness Visit scheduling, flu vaccination campaigns, mammogram completion outreach, patient intake history, readmission prevention calls, and life sciences work like adverse event detection and longitudinal follow-up for real-world evidence studies. You can filter agents by sector (provider, payor, pharma), by specialty (cardiology through urology), and by organizational goal (quality improvement, care management, health equity, call center management). The site lets you listen to four de-identified patient calls, including one where the agent picks up on subtle symptom cues and escalates to a human nurse. It's clear about the boundary too: the agents "do not diagnose or prescribe." The newest framing is "Orchestrators for Outcomes, Not Tasks," which suggests a push from single-purpose calls toward coordinating several agents around a goal, though the public site doesn't explain how that works in detail.

This is an enterprise sale. There's no self-serve signup or public price list, just a "Book A Meeting" button and a login for existing customers. If you're a solo developer hoping to plug a healthcare voice agent into an app this afternoon, it's not that. If you run outreach for a health system, a Medicare Advantage plan or a pharma patient services team and you're tired of watching quality measures slip because nobody has time to dial, it's one of the more focused options out there, with a heavy emphasis on safety research and published benchmarks to back up the clinical claims.